CAD 0.91
(-24.79%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -14.07 Million | -4.25 Million | -6.25 Million | -1.79 Million | -1.09 Million | -2249.00 |
Net Income | -9.3 Million | -10.52 Million | -9.31 Million | -3.53 Million | -1.14 Million | -83.5 Thousand |
Depreciation & Amortization | 952.5 Thousand | 326.49 Thousand | 140.99 Thousand | 103.39 Thousand | 102.14 Thousand | - |
Deferred income taxes | -4.45 Million | -49.44 Thousand | 13.72 Thousand | - | - | - |
Stock-based compensation | 373.55 Thousand | 1.96 Million | 2.46 Million | - | - | - |
Change in working capital | -2.31 Million | 3.63 Million | 198.48 Thousand | -245.09 Thousand | -228.09 Thousand | 51.18 Thousand |
Other non-cash items | 668.03 Thousand | 386.75 Thousand | 244.75 Thousand | 1.95 Million | 179.67 Thousand | 30.07 Thousand |
Investing Cash Flow | -1.44 Million | -1.11 Million | -1.07 Million | -390.97 Thousand | -20.19 Thousand | - |
Investments in PPE | -1.3 Million | -1.36 Million | -1.04 Million | -268.11 Thousand | -20.19 Thousand | - |
Acquisitions | 7811.00 | 250.34 Thousand | - | 78.58 Thousand | - | - |
Investment purchases | - | - | -30 Thousand | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -148.41 Thousand | 87.8 Thousand | -233.22 Thousand | -201.44 Thousand | - | - |
Financing Cash Flow | 20.75 Million | 2.85 Million | 6.94 Million | 5.23 Million | 1.13 Million | 136.5 Thousand |
Debt repayment | -2.4 Million | -102.5 Thousand | -568.4 Thousand | -1.04 Million | -109.01 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -612.00 | - | - | - | - | - |
Common Stock Issuance | 23.7 Million | 344 Thousand | 6 Million | 4.25 Million | - | 136.5 Thousand |
Other Financing Activities | -537.92 Thousand | 2.61 Million | 1.5 Million | -58.18 Thousand | 1.24 Million | - |
Accounts receivables | -568.62 Thousand | 1.05 Million | 1.01 Million | -257.58 Thousand | -41.46 Thousand | - |
Accounts payables | -1.66 Million | 2.51 Million | -828.69 Thousand | 393.2 Thousand | - | - |
Inventory | -148.85 Thousand | 49.44 Thousand | 17.55 Thousand | -1.00 | - | - |
Other working capital | 73.69 Thousand | 17.41 Thousand | -7053.00 | -380.7 Thousand | -186.62 Thousand | 51.18 Thousand |
Cash at beginning of period | 170.54 Thousand | 2.68 Million | 3.07 Million | 201.01 Thousand | - | 66.75 Thousand |
Cash at end of period | 5.4 Million | 170.54 Thousand | 2.68 Million | 3.07 Million | 21.61 Thousand | 201.01 Thousand |
Capital Expenditure | -1.3 Million | -1.36 Million | -1.04 Million | -268.11 Thousand | -20.19 Thousand | - |
Effect of forex changes on cash | - | - | - | -179.39 Thousand | - | - |
Net cash flow / Change in cash | 5.23 Million | -2.51 Million | -385.65 Thousand | 2.87 Million | 21.61 Thousand | 134.25 Thousand |
Free Cash Flow | -15.37 Million | -5.62 Million | -7.29 Million | -2.05 Million | -1.11 Million | -2249.00 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.16 Million | -3.54 Million | -398.97 Thousand | -9.3 Million | -2.41 Million | -3.45 Million |
Depreciation & Amortization | 321.97 Thousand | 319.65 Thousand | 321.42 Thousand | 952.5 Thousand | 342.87 Thousand | 285.75 Thousand |
Deferred income taxes | - | - | -2.13 Million | -4.45 Million | -1.54 Million | 427.34 Thousand |
Stock-based compensation | 59.13 Thousand | 60.98 Thousand | 63.48 Thousand | 373.55 Thousand | 57.29 Thousand | 39.21 Thousand |
Change in working capital | 272.23 Thousand | 399.93 Thousand | -768.04 Thousand | -2.31 Million | 781.73 Thousand | 442.35 Thousand |
Other non-cash items | -689.22 Thousand | 1.25 Million | 63.32 Thousand | 668.03 Thousand | 47.01 Thousand | 66.33 Thousand |
Investing Cash Flow | -25.87 Thousand | -23.29 Thousand | -46.11 Thousand | -1.44 Million | -450.27 Thousand | -106.61 Thousand |
Investments in PPE | -25.87 Thousand | -23.29 Thousand | -46.11 Thousand | -1.3 Million | -458.08 Thousand | -106.61 Thousand |
Acquisitions | - | - | - | 7811.00 | 7811.00 | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -4786.00 | - | - | -148.41 Thousand | 7811.00 | - |
Financing Cash Flow | 2.83 Million | -59.17 Thousand | -35.58 Thousand | 20.75 Million | 6.82 Million | 73.63 Thousand |
Debt repayment | -37.23 Thousand | -38.85 Thousand | -35.58 Thousand | -2.4 Million | -75.48 Thousand | -35.15 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -612.00 | - | - |
Common Stock Issuance | 2.85 Million | 522.00 | - | 23.7 Million | 7.35 Million | 4052.00 |
Other Financing Activities | 20.84 Thousand | -20.84 Thousand | - | -537.92 Thousand | -451.62 Thousand | 104.73 Thousand |
Accounts receivables | 160.64 Thousand | -101.67 Thousand | -613.87 Thousand | -568.62 Thousand | 678.71 Thousand | 170.98 Thousand |
Accounts payables | -150.86 Thousand | 305.26 Thousand | -197.7 Thousand | -1.66 Million | -737.87 Thousand | 928.42 Thousand |
Inventory | -6023.00 | -129.09 Thousand | 58.64 Thousand | -148.85 Thousand | 1.04 Million | -718.46 Thousand |
Other working capital | 268.49 Thousand | 325.43 Thousand | -15.1 Thousand | 73.69 Thousand | -207.7 Thousand | 61.4 Thousand |
Cash at beginning of period | 263.73 Thousand | 2.44 Million | 5.4 Million | 170.54 Thousand | 1.75 Million | 3.98 Million |
Cash at end of period | 1.17 Million | 263.73 Thousand | 2.47 Million | 5.4 Million | 5.4 Million | 1.75 Million |
Capital Expenditure | -25.87 Thousand | -23.29 Thousand | -46.11 Thousand | -1.3 Million | -458.08 Thousand | -106.61 Thousand |
Effect of forex changes on cash | - | - | - | - | 1.00 | -1.00 |
Net cash flow / Change in cash | 915.14 Thousand | -2.18 Million | -2.93 Million | 5.23 Million | 3.64 Million | -2.22 Million |
Free Cash Flow | -1.92 Million | -2.15 Million | -2.89 Million | -15.37 Million | -3.19 Million | -2.29 Million |
HIKAL
8075
KC
INDRAMEDCO
CBE
NKRKF